• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Monte Carlo simulation describing the pharmacodynamic profile of cefditoren in plasma from healthy volunteers.

作者信息

Granizo J J, Sádaba B, Honorato J, Gimenez M J, Sevillano D, Aguilar L, Coronel P

出版信息

Int J Antimicrob Agents. 2008 Apr;31(4):396-8. doi: 10.1016/j.ijantimicag.2007.10.024. Epub 2008 Jan 4.

DOI:10.1016/j.ijantimicag.2007.10.024
PMID:18178067
Abstract
摘要

相似文献

1
Monte Carlo simulation describing the pharmacodynamic profile of cefditoren in plasma from healthy volunteers.描述头孢妥仑在健康志愿者血浆中药代动力学特征的蒙特卡洛模拟。
Int J Antimicrob Agents. 2008 Apr;31(4):396-8. doi: 10.1016/j.ijantimicag.2007.10.024. Epub 2008 Jan 4.
2
Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.使用群体药代动力学建模和蒙特卡洛模拟来描述头孢妥仑在血浆和上皮衬液中的药效学特征。
Antimicrob Agents Chemother. 2008 Jun;52(6):1945-51. doi: 10.1128/AAC.00736-06. Epub 2007 May 7.
3
Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients.头孢吡肟在腹部手术患者血浆和腹水中的药代动力学和药效学分析
Int J Antimicrob Agents. 2007 Sep;30(3):270-3. doi: 10.1016/j.ijantimicag.2007.04.012. Epub 2007 Jun 22.
4
Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.基于群体药代动力学和药效学分析的发热性中性粒细胞减少症患者头孢唑兰优化剂量和给药频率
J Antimicrob Chemother. 2008 Apr;61(4):892-900. doi: 10.1093/jac/dkn038. Epub 2008 Feb 13.
5
Monte Carlo simulations.蒙特卡洛模拟
Methods Mol Biol. 2008;443:25-36. doi: 10.1007/978-1-59745-177-2_2.
6
Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate.美罗培南在新生儿中的药代动力学、药效学及蒙特卡洛模拟
Pediatr Infect Dis J. 2008 Sep;27(9):794-9. doi: 10.1097/INF.0b013e318170f8d2.
7
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.脓毒症且无肾功能不全的危重症患者的美罗培南给药：静脉推注与持续给药对比？蒙特卡洛模拟给药及皮下组织分布情况
J Antimicrob Chemother. 2009 Jul;64(1):142-50. doi: 10.1093/jac/dkp139. Epub 2009 Apr 27.
8
Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients.多利培南在感染患者中的药代动力学-药效学达标分析
Int J Antimicrob Agents. 2009 Mar;33(3):276-9. doi: 10.1016/j.ijantimicag.2008.08.031. Epub 2008 Dec 17.
9
Application of patient population-derived pharmacokinetic-pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci.源自患者群体的药代动力学-药效学关系在葡萄球菌和链球菌替加环素断点确定中的应用
Diagn Microbiol Infect Dis. 2009 Feb;63(2):155-9. doi: 10.1016/j.diagmicrobio.2008.10.011.
10
Pharmacodynamic assessment of doripenem in peritoneal fluid against Gram-negative organisms: use of population pharmacokinetic modeling and Monte Carlo simulation.多利培南在腹膜液中对革兰氏阴性菌的药效学评估：群体药代动力学建模与蒙特卡洛模拟的应用
Diagn Microbiol Infect Dis. 2008 Nov;62(3):292-7. doi: 10.1016/j.diagmicrobio.2008.06.016. Epub 2008 Aug 13.

引用本文的文献

1
Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model.关于该文章的评论：头孢妥仑匹酯在小鼠肺部感染模型中针对肺炎链球菌的合适剂量的体内药代动力学/药效学特征。
Pharm Res. 2024 Aug;41(8):1595-1597. doi: 10.1007/s11095-024-03729-8. Epub 2024 Jul 13.
2
[Role of cefditoren in the treatment of community skin and soft tissue infections: revisiting the evidence].头孢妥仑在社区获得性皮肤及软组织感染治疗中的作用：重新审视相关证据
Rev Esp Quimioter. 2021 Jun;34(3):185-192. doi: 10.37201/req/063.2021. Epub 2021 May 24.
3
Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.
重新审视头孢妥仑用于治疗成人由人适应性呼吸道病原体引起的社区获得性感染。
Multidiscip Respir Med. 2018 Nov 2;13:40. doi: 10.1186/s40248-018-0152-5. eCollection 2018.
4
Seventy-Five Years of Research on Protein Binding.七十五年来的蛋白质结合研究。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01663-17. Print 2018 Feb.
5
Update on the clinical utility and optimal use of cefditoren.头孢地尼的临床实用性和最佳使用方法的最新进展。
Int J Gen Med. 2012;5:455-64. doi: 10.2147/IJGM.S25989. Epub 2012 May 21.
6
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.社区获得性呼吸道感染中的耐药性：新兴抗菌药物的作用。
Infect Drug Resist. 2010;3:35-43. doi: 10.2147/idr.s8964. Epub 2010 Jun 18.
7
Cefditoren in upper and lower community-acquired respiratory tract infections.头孢地尼用于上下呼吸道社区获得性感染
Drug Des Devel Ther. 2011 Feb 9;5:85-94. doi: 10.2147/DDDT.S9499.
8
Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model.在败血症模型中，预先免疫的小鼠体内头孢妥仑对青霉素耐药性肺炎链球菌（血清型 6B、19F 和 23F）的活性增强。
PLoS One. 2010 Aug 10;5(8):e12041. doi: 10.1371/journal.pone.0012041.
9
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).西班牙呼吸道病原体的抗生素耐药性：11 年间（1996-1997 年至 2006-2007 年）的最新数据和变化。
Antimicrob Agents Chemother. 2010 Jul;54(7):2953-9. doi: 10.1128/AAC.01548-09. Epub 2010 May 3.
10
High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation.高蛋白结合率及对青霉素耐药肺炎链球菌的杀菌活性：头孢妥仑体外药效学模拟
PLoS One. 2008 Jul 23;3(7):e2717. doi: 10.1371/journal.pone.0002717.